AbbVie Partner Spotlight

Featured

Sponsored by AbbVie Medical Affairs
Sponsored by AbbVie Medical Affairs
09/15/2022
  Axial spondyloarthritis (axSpA) diseases, consisting of radiographic axSpA (ankylosing spondylitis) and non-radiographic axSpA, are inflammatory arthritides that mainly affect the axial skeleton,...
09/15/2022

Articles

Sponsored by AbbVie Medical Affairs
Sponsored by AbbVie Medical Affairs
03/11/2022
Treatment goals can be challenging for those with RA who are bDMARD-IR. Hear Dr. Tesser’s approach and learn about SELECT-BEYOND, where a JAK inhibitor was assessed in such patients.
03/11/2022
Sponsored by AbbVie Medical Affairs
Sponsored by AbbVie Medical Affairs
05/04/2022
Many patients with PsA cannot achieve comprehensive control of their symptoms, despite a variety of available treatments. Learn more about an available JAK inhibitor along with findings from the two phase 3...
05/04/2022
Sponsored by AbbVie Medical Affairs
Sponsored by AbbVie Medical Affairs
10/21/2022
An existing medication was recently approved by the US Food and Drug Administration for use in individuals with active psoriatic arthritis. Learn more about the study data leading to this expanded...
10/21/2022